• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MR1/黏膜相关恒定T细胞轴增强阿尔茨海默病中营养不良性神经突的发育。

The MR1/MAIT cell axis enhances dystrophic neurite development in Alzheimer's disease.

作者信息

Wyatt-Johnson Season K, Ackley Samantha, Warren Jalyn, Priya Raj, Wan Jun, Liu Sheng, Brutkiewicz Randy R

机构信息

Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.

出版信息

Alzheimers Dement. 2025 Feb;21(2):e14480. doi: 10.1002/alz.14480. Epub 2025 Jan 8.

DOI:10.1002/alz.14480
PMID:39777865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11848147/
Abstract

INTRODUCTION

Plaques are a hallmark feature of Alzheimer's disease (AD). We found that the loss of mucosal-associated invariant T (MAIT) cells and their antigen-presenting molecule MR1 caused a delay in plaque pathology development in AD mouse models. However, it remains unknown how this axis is impacting dystrophic neurites.

METHODS

Brain tissue from 5XFAD mice and those that are MR1 deficient (MR1 KO), were analyzed for dystrophic neurites, amyloid plaques, and synapses via immunofluorescence, RNA sequencing, enzyme-linked immunosorbent assay, and western blot.

RESULTS

In 8-month-old 5XFAD/MR1 KO mice, there was reduced expression of lysosomal-associated membrane protein 1, ubiquitin, and n-terminal amyloid precursor protein in the hippocampus compared to 5XFAD mice (P < 0.05). 5XFAD/MR1 KO mice also had less insoluble amyloid beta 40 (P < 0.001) and higher levels of postsynaptic density protein 95 (P < 0.01) in the hippocampus.

DISCUSSION

Our data contribute additional mechanistic insight into the detrimental role of the MR1/MAIT cell axis in AD pathology development.

HIGHLIGHTS

5XFAD mice lacking the innate immune MR1/MAIT (mucosal-associated invariant T) cell axis (5XFAD/MR1 KO) have reduced numbers of dystrophic neurite markers in the hippocampus at 8 months of age. Hippocampal tissue transcriptional analyses showed reduced expression of genes encoding classical dystrophic neurite markers in 5XFAD/MR1 KO mice. 5XFAD/MR1 KO mice had less insoluble amyloid beta 40 and increased levels of the post-synaptic marker, postsynaptic density protein 95, in the hippocampus than did MR1+ 5XFAD mice.

摘要

引言

斑块是阿尔茨海默病(AD)的标志性特征。我们发现黏膜相关恒定T(MAIT)细胞及其抗原呈递分子MR1的缺失导致AD小鼠模型中斑块病理学发展延迟。然而,该轴如何影响营养不良性神经突仍不清楚。

方法

通过免疫荧光、RNA测序、酶联免疫吸附测定和蛋白质免疫印迹法,对5XFAD小鼠和MR1缺陷(MR1敲除)小鼠的脑组织进行营养不良性神经突、淀粉样斑块和突触分析。

结果

与5XFAD小鼠相比,8月龄的5XFAD/MR1敲除小鼠海马中溶酶体相关膜蛋白1、泛素和淀粉样前体蛋白N端的表达降低(P<0.05)。5XFAD/MR1敲除小鼠海马中不溶性淀粉样β40也较少(P<0.001),突触后致密蛋白95水平较高(P<0.01)。

讨论

我们的数据为MR1/MAIT细胞轴在AD病理发展中的有害作用提供了更多的机制性见解。

要点

缺乏先天免疫MR1/MAIT(黏膜相关恒定T)细胞轴的5XFAD小鼠(5XFAD/MR1敲除)在8月龄时海马中营养不良性神经突标志物数量减少。海马组织转录分析显示,5XFAD/MR1敲除小鼠中编码经典营养不良性神经突标志物的基因表达降低。与MR1+5XFAD小鼠相比,5XFAD/MR1敲除小鼠海马中不溶性淀粉样β40较少,突触后标志物突触后致密蛋白95水平升高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/ddb50dab45fd/ALZ-21-e14480-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/bcbaf49a87b8/ALZ-21-e14480-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/453476acab62/ALZ-21-e14480-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/9d033ce5e7c1/ALZ-21-e14480-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/edc8c0a7d9c1/ALZ-21-e14480-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/9b9f06f702b5/ALZ-21-e14480-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/ddb50dab45fd/ALZ-21-e14480-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/bcbaf49a87b8/ALZ-21-e14480-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/453476acab62/ALZ-21-e14480-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/9d033ce5e7c1/ALZ-21-e14480-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/edc8c0a7d9c1/ALZ-21-e14480-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/9b9f06f702b5/ALZ-21-e14480-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9042/11848147/ddb50dab45fd/ALZ-21-e14480-g006.jpg

相似文献

1
The MR1/MAIT cell axis enhances dystrophic neurite development in Alzheimer's disease.MR1/黏膜相关恒定T细胞轴增强阿尔茨海默病中营养不良性神经突的发育。
Alzheimers Dement. 2025 Feb;21(2):e14480. doi: 10.1002/alz.14480. Epub 2025 Jan 8.
2
Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer's disease model mice.膜联蛋白A6膜修复蛋白在阿尔茨海默病模型小鼠中可预防淀粉样蛋白诱导的营养不良性神经突和tau蛋白磷酸化。
Acta Neuropathol. 2025 May 24;149(1):51. doi: 10.1007/s00401-025-02888-1.
3
Control of the temporal development of Alzheimer's disease pathology by the MR1/MAIT cell axis.通过 MR1/MAIT 细胞轴控制阿尔茨海默病病理的时间发展。
J Neuroinflammation. 2023 Mar 21;20(1):78. doi: 10.1186/s12974-023-02761-6.
4
Pregabalin Treatment does not Affect Amyloid Pathology in 5XFAD Mice.普瑞巴林治疗不会影响 5XFAD 小鼠的淀粉样蛋白病理。
Curr Alzheimer Res. 2021;18(4):283-297. doi: 10.2174/1567205018666210713125333.
5
Amyloid-β plaque-associated microglia drive TSPO upregulation in Alzheimer's disease.淀粉样β蛋白斑块相关的小胶质细胞驱动阿尔茨海默病中转运体蛋白18 kDa(TSPO)的上调。
Acta Neuropathol. 2025 Jul 17;150(1):6. doi: 10.1007/s00401-025-02912-4.
6
Co-Aggregation of Syndecan-3 with β-Amyloid Aggravates Neuroinflammation and Cognitive Impairment in 5×FAD Mice.Syndecan-3与β-淀粉样蛋白的共聚集加重5×FAD小鼠的神经炎症和认知障碍。
Int J Mol Sci. 2025 Jun 8;26(12):5502. doi: 10.3390/ijms26125502.
7
Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model.下调阿尔茨海默病中升高的 Wnt 拮抗剂 Dickkopf-3,可恢复疾病模型小鼠的突触完整性和记忆。
Elife. 2024 Jan 29;12:RP89453. doi: 10.7554/eLife.89453.
8
PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer's disease.PLCG2 与炎症反应有关,并且由阿尔茨海默病中的淀粉样斑块诱导。
Genome Med. 2022 Feb 18;14(1):17. doi: 10.1186/s13073-022-01022-0.
9
The MR1/MAIT cell axis in CNS diseases.中枢神经系统疾病中的MR1/黏膜相关恒定T细胞轴
Brain Behav Immun. 2024 Feb;116:321-328. doi: 10.1016/j.bbi.2023.12.029. Epub 2023 Dec 27.
10
Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.寡甘露糖二酸以性别特异性方式改变肠道微生物群,减少脑淀粉样蛋白沉积和反应性小胶质细胞。
Mol Neurodegener. 2024 Feb 17;19(1):18. doi: 10.1186/s13024-023-00700-w.

引用本文的文献

1
The MR1/MAIT cell axis impacts the gut-brain axis through both cognition and microbial community structure in 5XFAD mice.在5XFAD小鼠中,MR1/MAIT细胞轴通过认知和微生物群落结构影响肠-脑轴。
Alzheimers Dement. 2025 Jul;21(7):e70493. doi: 10.1002/alz.70493.
2
2D and 3D Models of Alzheimer's Disease: Investigating Neuron-like Cells in Oxidative Environments.阿尔茨海默病的二维和三维模型:在氧化环境中研究类神经元细胞。
ACS Omega. 2025 Jun 16;10(25):27501-27514. doi: 10.1021/acsomega.5c03306. eCollection 2025 Jul 1.

本文引用的文献

1
Enrichment of liver MAIT cells in a mouse model of Alzheimer's disease.在阿尔茨海默病小鼠模型中肝脏 MAIT 细胞的富集。
J Neuroimmunol. 2024 May 15;390:578332. doi: 10.1016/j.jneuroim.2024.578332. Epub 2024 Mar 21.
2
The immune system in neurological diseases: What innate-like T cells have to say.神经疾病中的免疫系统:固有样 T 细胞有话要说。
J Allergy Clin Immunol. 2024 Apr;153(4):913-923. doi: 10.1016/j.jaci.2024.02.003. Epub 2024 Feb 15.
3
The MR1/MAIT cell axis in CNS diseases.中枢神经系统疾病中的MR1/黏膜相关恒定T细胞轴
Brain Behav Immun. 2024 Feb;116:321-328. doi: 10.1016/j.bbi.2023.12.029. Epub 2023 Dec 27.
4
Neuritic Plaques - Gateways to Understanding Alzheimer's Disease.神经炎性斑块——理解阿尔茨海默病的关键切入点
Mol Neurobiol. 2024 May;61(5):2808-2821. doi: 10.1007/s12035-023-03736-7. Epub 2023 Nov 8.
5
Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update.抗淀粉样蛋白免疫疗法治疗阿尔茨海默病:2023 年临床更新。
Neurotherapeutics. 2023 Jul;20(4):914-931. doi: 10.1007/s13311-023-01405-0. Epub 2023 Jul 25.
6
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.多奈哌齐治疗早期症状性阿尔茨海默病的随机临床试验。
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
7
Most dystrophic neurites in the common 5xFAD Alzheimer mouse model originate from axon terminals.在常见的 5xFAD 阿尔茨海默病小鼠模型中,大多数营养不良的神经突起源于轴突末梢。
Neurobiol Dis. 2023 Jun 15;182:106150. doi: 10.1016/j.nbd.2023.106150. Epub 2023 May 10.
8
Tau-targeting antisense oligonucleotide MAPT in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.靶向 Tau 的反义寡核苷酸 MAPT 治疗轻度阿尔茨海默病的 1b 期、随机、安慰剂对照试验。
Nat Med. 2023 Jun;29(6):1437-1447. doi: 10.1038/s41591-023-02326-3. Epub 2023 Apr 24.
9
Control of the temporal development of Alzheimer's disease pathology by the MR1/MAIT cell axis.通过 MR1/MAIT 细胞轴控制阿尔茨海默病病理的时间发展。
J Neuroinflammation. 2023 Mar 21;20(1):78. doi: 10.1186/s12974-023-02761-6.
10
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.